These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 17766283)

  • 1. Arterial remodelling: an independent pathophysiological component of atherosclerotic disease progression and regression. Insights from serial pharmacological intervention trials.
    Schoenhagen P; Sipahi I
    Eur Heart J; 2007 Oct; 28(19):2299-300. PubMed ID: 17766283
    [No Abstract]   [Full Text] [Related]  

  • 2. ACE inhibition in stable coronary artery disease.
    Hackam DG
    CMAJ; 2003 Oct; 169(9):939. PubMed ID: 14581315
    [No Abstract]   [Full Text] [Related]  

  • 3. [PROGRESS trial].
    Yoshimura Y; Shimada K
    Nihon Rinsho; 2006 Oct; 64 Suppl 7():501-5. PubMed ID: 17461196
    [No Abstract]   [Full Text] [Related]  

  • 4. Blood pressure lowering in PROGRESS (Perindopril Protection Against Recurrent Stroke Study) and white matter hyperintensities: should this progress matter to patients?
    Schiffrin EL
    Circulation; 2005 Sep; 112(11):1525-6. PubMed ID: 16157782
    [No Abstract]   [Full Text] [Related]  

  • 5. [Angiotensin-converting enzyme inhibitors and chronic ischemic heart disease--new indications?].
    Haghfelt T; Haghfelt A
    Ugeskr Laeger; 2004 Jan; 166(3):169-70. PubMed ID: 14870648
    [No Abstract]   [Full Text] [Related]  

  • 6. EUROPA: clinical benefits, clinical promise.
    Cardiovasc J S Afr; 2004; 15(3):147. PubMed ID: 15356915
    [No Abstract]   [Full Text] [Related]  

  • 7. Renin angiotensin blockade in heart failure with preserved ejection fraction: The signal gets stronger.
    McMurray J
    Eur Heart J; 2006 Oct; 27(19):2257-9. PubMed ID: 16963471
    [No Abstract]   [Full Text] [Related]  

  • 8. [Scientific value of the EUROPA Study: mechanisms of beneficial effect of perindopril in atherosclerosis].
    Karpov IuA
    Kardiologiia; 2005; 45(2):86-9. PubMed ID: 15798719
    [No Abstract]   [Full Text] [Related]  

  • 9. The cardioprotective effects of the angiotensin-converting enzyme inhibitor perindopril in patients with stable coronary artery disease are not modified by mild to moderate renal insufficiency: insights from the EUROPA trial.
    Brugts JJ; Boersma E; Chonchol M; Deckers JW; Bertrand M; Remme WJ; Ferrari R; Fox K; Simoons ML;
    J Am Coll Cardiol; 2007 Nov; 50(22):2148-55. PubMed ID: 18036453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The consistency of the treatment effect of an ACE-inhibitor based treatment regimen in patients with vascular disease or high risk of vascular disease: a combined analysis of individual data of ADVANCE, EUROPA, and PROGRESS trials.
    Brugts JJ; Ninomiya T; Boersma E; Remme WJ; Bertrand M; Ferrari R; Fox K; MacMahon S; Chalmers J; Simoons ML
    Eur Heart J; 2009 Jun; 30(11):1385-94. PubMed ID: 19346520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Type 2 diabetes. Routine ACE inhibitors?].
    Hönl SB
    Med Monatsschr Pharm; 2008 Apr; 31(4):149-50. PubMed ID: 18497249
    [No Abstract]   [Full Text] [Related]  

  • 12. Does ACE inhibitor therapy delay onset and progression of cardiac dysfunction in duchenne muscular dystrophy?
    Hirano M
    Curr Neurol Neurosci Rep; 2006 Jan; 6(1):35-6. PubMed ID: 16469269
    [No Abstract]   [Full Text] [Related]  

  • 13. Angiotensin-converting enzyme inhibition by perindopril in the treatment of cardiovascular disease.
    Brugts JJ; Ferrari R; Simoons ML
    Expert Rev Cardiovasc Ther; 2009 Apr; 7(4):345-60. PubMed ID: 19379059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combine EUROPA and HOPE.
    Fuller JA
    Lancet; 2003 Dec; 362(9399):1937. PubMed ID: 14667761
    [No Abstract]   [Full Text] [Related]  

  • 15. [Ramipril can do more. Halting progression of atherosclerosis].
    MMW Fortschr Med; 2001 Sep; 143(35-36):45. PubMed ID: 11584530
    [No Abstract]   [Full Text] [Related]  

  • 16. Update on the management of atherosclerotic renal artery disease.
    Fenstad ER; Kane GC
    Minerva Cardioangiol; 2009 Feb; 57(1):95-101. PubMed ID: 19202521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Need of tight blood pressure control in type 2 diabetes. The intervention study ADVANCE gives clear information].
    Nilsson PM
    Lakartidningen; 2007 Oct 17-23; 104(42):3028-9. PubMed ID: 17985709
    [No Abstract]   [Full Text] [Related]  

  • 18. Consistency of treatment effect of perindopril and indapamide across broad spectrum of vascular disease.
    Cardiovasc J Afr; 2009; 20(3):206. PubMed ID: 19575093
    [No Abstract]   [Full Text] [Related]  

  • 19. Did they lower stress in the trial? Or was it just wasted energy?
    Sanders SP
    J Am Coll Cardiol; 2005 Mar; 45(6):858-9. PubMed ID: 15766819
    [No Abstract]   [Full Text] [Related]  

  • 20. [Antihypertensive therapy in diabetic patients. What do the new data mean for the practice?].
    Holzgreve H
    MMW Fortschr Med; 2007 Sep; 149(38):19. PubMed ID: 18018408
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.